PetMeds Gets Lowball $3 Buyout Bid After $4 Offer Rejected
SilverCape Investments cut its acquisition offer for PetMed Express to $3 a share, down from a prior $4 bid made last December.
PetMed Express just got a second unsolicited takeover bid — and this one's actually lower than the first. SilverCape Investments Limited came back to the table with a $3-per-share cash offer for all outstanding shares of the Nasdaq-listed pet pharmacy company (ticker: PETS), down a full dollar from its original $4-per-share proposal floated back on December 11, 2025.
The company's board confirmed receipt of the new offer but hasn't said it's biting. Both proposals carry the same cautionary labels: unsolicited, non-binding, and conditional. That's deal-speak for 'don't pop the champagne yet.' SilverCape hasn't locked in financing, hasn't signed a thing, and management isn't obligated to engage.
Read more Owens Corning Gets Evercore Upgrade on Carlisle Buyout Buzz →
Here's what should grab your attention as a trader: the acquirer went *lower* on the second swing. That's unusual. Typically follow-up bids go up when a company plays hard to get. A downward revision signals either SilverCape thinks PETS is in a weaker position, or they're testing the floor before negotiating upward. Either way, it's a tell.
PetMeds is a Delray Beach, Florida-based online pet pharmacy that has faced headwinds from competition and shifting consumer behavior in the pet health space. The stock's reaction to this new bid will be a real-time referendum on whether the market believes a deal gets done — and at what price. Watch the spread between the current share price and $3.00 closely; that gap tells you everything about deal confidence right now.
Continue reading at GlobalNewswire.
